🇺🇸 FDA
Pipeline program

MK-7480 Multiple Ascending Dose Study in Healthy Participants

MK-7480-002

Phase 1 other active

Quick answer

MK-7480 Multiple Ascending Dose Study in Healthy Participants for Non-alcoholic steatohepatitis is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Non-alcoholic steatohepatitis
Phase
Phase 1
Modality
other
Status
active

Clinical trials